Emerging Role of Precision Medicine in Diagnosis and Treatment of Chronic Respiratory Disease
Downloads
Precision medicine is the current approach to managing chronic respiratory diseases, especially asthma and chronic obstructive pulmonary disease (COPD). It involves the evaluation of genetic, environmental, and lifestyle variations for each patient. It requires valid and specific biomarkers obtained through genetic studies, biomolecular technology, and omics-based technology to determine targeted therapies. Asthma and COPD have heterogeneous clinical phenotype variations, and giving one standard treatment for asthma and COPD may not necessarily provide the same effectiveness to other patients. The endotype, a specific molecular mechanism in disease pathogenesis, is essential in phenotype variation. The role of precision medicine in asthma and COPD is to determine endotypes through specific biomarkers and to provide specific targeted therapy for achieving personalized treatment in each patient. The application of precision medicine not only provides precise diagnosis and treatment but also enables early detection in individuals at risk and prevention of progression and exacerbation in asthma and COPD.
König IR, Fuchs O, Hansen G, et al. What is Precision Medicine? Eur Respir J; 50. Epub ahead of print October 2017. [PubMed]
Jameson JL, Longo DL. Precision Medicine--Personalized, Problematic, and Promising. N Engl J Med 2015; 372: 2229–2234. [PubMed]
Leung JM, Obeidat M, Sadatsafavi M, et al. Introduction to Precision Medicine in COPD. Eur Respir J; 53. Epub ahead of print April 2019. [PubMed]
Naithani N, Atal AT, Tilak TVSVGK, et al. Precision Medicine: Uses and Challenges. Med Journal, Armed Forces India 2021; 77: 258–265. [PubMed]
Hizawa N. The Understanding of Asthma Pathogenesis in the Era of Precision Medicine. Allergol Int 2023; 72: 3–10. [PubMed]
Agustí A, Bafadhel M, Beasley R, et al. Precision Medicine in Airway Diseases: Moving to Clinical Practice. Eur Respir J; 50. Epub ahead of print October 2017. [PubMed]
Tejera P, Jardim J, Laucho-Contreras ME. Editorial: Precision Medicine in Pulmonary Diseases-Same Principles, New Approach. Frontiers in Medicine 2021; 8: 821013. [PubMed]
Martinez-Garcia MA, Campos-Rodriguez F, Barbé F, et al. Precision Medicine in Obstructive Sleep Apnoea. Lancet Respir Med 2019; 7: 456–464. [PubMed]
Pembridge T, Chalmers JD. Precision Medicine in Bronchiectasis. Breathe (Sheffield, England) 2021; 17: 210119. [PubMed]
Agustí A. Predicting the Future from the Past. Eur Respir J 2017; 49: 1601854. [Journal]
Agusti A, Faner R, Celli B, et al. Precision Medicine in COPD Exacerbations. Lancet Respir Med 2018; 6: 657–659. [PubMed]
Sarma A, Calfee CS, Ware LB. Biomarkers and Precision Medicine: State of the Art. Crit Care Clin 2020; 36: 155–165. [PubMed]
Carr TF, Peters MC. Novel Potential Treatable Traits in Asthma: Where is the Research Taking Us? J Allergy Clin Immunol Glob 2022; 1: 27–36. [PubMed]
Marques A, Souto-Miranda S, Machado A, et al. COPD Profiles and Treatable Traits Using Minimal Resources: Identification, Decision Tree and Stability Over Time. Respir Res 2022; 23: 30. [Journal]
Papaioannou AI, Diamant Z, Bakakos P, et al. Towards Precision Medicine in Severe Asthma: Treatment Algorithms Based on Treatable Traits. Respir Med 2018; 142: 15–22. [PubMed]
Kan M, Shumyatcher M, Himes BE. Using Omics Approaches to Understand Pulmonary Diseases. Respir Res 2017; 18: 149. [PubMed]
Abdel-Aziz MI, Neerincx AH, Vijverberg SJ, et al. Omics for the Future in Asthma. Semin Immunopathol 2020; 42: 111–126. [PubMed]
Kuruvilla ME, Lee FE-H, Lee GB. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin Rev Allergy Immunol 2019; 56: 219–233. [PubMed]
Rogers GB, Wesselingh S. Precision Respiratory Medicine and the Microbiome. Lancet Respir Med 2016; 4: 73–82. [PubMed]
Kozik AJ, Holguin F, Segal LN, et al. Microbiome, Metabolism, and Immunoregulation of Asthma: An American Thoracic Society and National Institute of Allergy and Infectious Diseases Workshop Report. Am J Respir Cell Mol Biol 2022; 67: 155–163. [PubMed]
Budden KF, Shukla SD, Rehman SF, et al. Functional Effects of the Microbiota in Chronic Respiratory Disease. Lancet Respir Med 2019; 7: 907–920. [PubMed]
Manian P. Chronic Obstructive Pulmonary Disease Classification, Phenotypes and Risk Assessment. J Thorac Dis 2019; 11: S1761–S1766. [PubMed]
Garudadri S, Woodruff PG. Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers. Ann Am Thorac Soc 2018; 15: S234–S238. [PubMed]
Stockley RA, Halpin DMG, Celli BR, et al. Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation. Am J Respir Crit Care Med 2019; 199: 1195–1204. [PubMed]
García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, et al. Biomarcadores Biológicos en Las Enfermedades Respiratorias. Arch Bronconeumol 2022; 58: 323–333. [ScienceDirect]
Celli BR, Anderson JA, Brook R, et al. Serum Biomarkers and Outcomes in Patients with Moderate COPD: A Substudy of the Randomised SUMMIT Trial. BMJ Open Respir Res 2019; 6: e000431. [PubMed]
Schleich F, Bougard N, Moermans C, et al. Cytokine-Targeted Therapies for Asthma and COPD. Eur Respir Rev; 32. Epub ahead of print June 2023. [PubMed]
Scelfo C, Galeone C, Bertolini F, et al. Towards Precision Medicine: The Application of Omics Technologies in Asthma Management. F1000Research 2018; 7: 423. [PubMed]
Kaur R, Chupp G. Phenotypes and Endotypes of Adult Asthma: Moving toward Precision Medicine. J Allergy Clin Immunol 2019; 144: 1–12. [PubMed]
Yudhawati R, Guntur MRN. Biological Therapy for Asthma. J Respirasi 2021; 7: 27–35. [Journal]
Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J; 61. Epub ahead of print April 2023. [PubMed]
Raita Y, Camargo CAJ, Liang L, et al. Leveraging ‘Big Data' in Respiratory Medicine - Data Science, Causal Inference, and Precision Medicine. Expert Review of Respiratory Medicine 2021; 15: 717–721. [PubMed]
González Burchard E, Borrell LN. Need for Racial and Ethnic Diversity in Asthma Precision Medicine. The New England Journal of Medicine 2021; 385: 2297–2298. [PubMed]
Raita Y, Camargo CAJ, Liang L, et al. Big Data, Data Science, and Causal Inference: A Primer for Clinicians. Front Med 2021; 8: 678047. [PubMed]
Sankar PL, Parker LS. The Precision Medicine Initiative's All of Us Research Program: An Agenda for Research on Its Ethical, Legal, and Social Issues. Genet Med 2017; 19: 743–750. [PubMed]
Copyright (c) 2024 Made Agustya Darma Putra Wesnawa, Oke Dimas Asmara, I Gede Putu Supadmanaba
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.